Research programme: small molecule therapeutic - 4SC/Sanwa Kagaku Kenkyusho

Drug Profile

Research programme: small molecule therapeutic - 4SC/Sanwa Kagaku Kenkyusho

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator 4SC; Sanwa Kagaku Kenkyusho
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Diabetes mellitus

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Diabetes-mellitus in Japan
  • 30 Apr 2012 Preclinical development is in progress in Japan
  • 07 Dec 2006 4SC AG announced that the cooperation with Sanwa Kagaku Kenkyusho on the optimised target in the area of diabetes was completed in September 2006
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top